跳至主要内容
临床试验/NCT02355691
NCT02355691终止不适用

Improvement in Wound Healing With Negative Pressure Wound Therapy for Postoperative Total Hip Arthroplasty

University of North Carolina, Chapel Hill2 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2015年5月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
16
试验地点
2
主要终点
Mean Wound Healing Scores by the ASEPSIS Criteria

研究概览

简要总结

For the target population of adult patients following primary total hip arthroplasty, the randomized clinical trial will be used to evaluate the efficacy of the use of a mobile negative pressure wound therapy(NPWT) device compared to a standard absorptive dressing in the immediate postoperative period. We will apply two dressing types and evaluate the postoperative wounds with a wound scoring system (ASEPSIS) that incorporates multiple variables of wound infection risk.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients undergoing primary total hip arthroplasty.

排除标准

  • age less than 18 y/o
  • Total hip arthroplasty for fracture
  • Revision or conversion total hip arthroplasty
  • inability to personally consent to participation due to cognitive impairment, intoxication or sedation
  • multiple surgical procedures
  • Patients taking immune modulating medication(prednisone, methotrexate, anakinra, etc.)
  • skin hypersensitivity to acrylic adhesive or silver.
  • Inability to care for dressing due to physical or mental incapacitation

研究组 & 干预措施

Standard group

No Intervention

Patients will be treated with the standard absorptive dressing following total hip arthroplasty.

PREVENA Group

Experimental

Patients will be treated with the PREVENA negative pressure device following total hip arthroplasty. This dressing will be used for a period of seven days.

干预措施: PREVENA (Device)

结局指标

主要结局

Mean Wound Healing Scores by the ASEPSIS Criteria

时间窗: (Single point evaluation)-2 weeks post surgery visit

A method of evaluating wounds for infection risk that incorporates multiple wound healing factors such as erythema, drainage, and dehiscence is the ASEPSIS (Additional treatment, presence of Serous discharge, Erythema, Purulent exudate, Separation of the deep tissue, Isolation of bacteria, and duration of inpatient Stay) wound scoring system. Originally developed and validated for cardiac surgery sternal wounds, ASEPSIS evaluates the wound for the severity of multiple factors linked with surgical site infection. This includes dehiscence, exudate/discharge, and erythema. The higher the score, the more likely a surgical site infection will be present. This score will give us a more diverse picture of postoperative wound healing and the influence of Negative Pressure Wound Therapy. Scores can range from 0 to 65, with most scores expected at the lower scale.

次要结局

  • Number of Participants With Infection((Single point evaluation)-6 weeks post surgery visit)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验